title: [Effectiveness of intraperitoneal chemotherapy in combined treatment of gastric cancer].
abstract: The schemes of postoperative intraperitoneal chemotherapy and polychemotherapy of gastric cancer have been developed. In their use, the 2-year survival of the patients increased by 17.2%, in absence of regional metastases--by 40%, in their presence--by 16.1%, in endophytic growth of tumors--by 14.3%, in exophytic growth--by 11.8% when compared with the results of surgical treatment alone.
authors.forename: I B
authors.initials: IB
authors.lastname: Shchepotin
authors.forename: V A
authors.initials: VA
authors.lastname: Chernyĭ
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D006801:Humans; D007274:Injections, Intraperitoneal; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000601:surgery; D013997:Time Factors
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Effektivnost' vnutribriushinnoĭ khimioterapii v kombinirovannom lechenii raka zheludka.